Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CogniMS observational study in early multiple sclerosis
2005-005989-37Phase 4Completed
- Sponsor
- Bayer
- Start
- Feb 2006
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon beta-1a in multiple sclerosis (MS), sponsored by Bayer. Primary endpoint: Observational assessment of cognition. Started Feb 2006; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2005-005989-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005989-37.